Search results
Results from the WOW.Com Content Network
Labcorp has been criticized over faulty paternity tests, many of which have resulted in lawsuits. The most notable case was the 2005 false accusation of Washington hairdresser Andre Chreky, who spent $200,000 and years in court proving, despite a false-positive test, that he was not the father.
Monogram Biosciences, Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA and is a subsidiary of LabCorp. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.
After extraction, all specimen containers must be labeled with at least two of the following identifiers (at the time of collection): patient's name, date of birth, hospital number, test request form number, accession number, or a unique random number. All specimens should be labeled with the patient present.
In June 2021, the company changed its name to Labcorp Drug Development. [55] In February 2023, the company was renamed Fortrea Holdings. [56] In July 2023, Labcorp completed the corporate spin-off of the company. [57] In June 2024, the company sold its Endpoint Clinical and Fortrea Patient Access businesses to Arsenal Capital Partners. [58]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Quest Diagnostics Incorporated is an American clinical laboratory.A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. [3] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. [2]In 2017, Invitae acquired Good Start Genetics and CombiMatrix.
The two companies also stated that they entered into an agreement to work together to form a “jointly owned national Esoteric Anatomic Pathology reference laboratory offering.” [7] On February 28, 2017, just a week after Laboratory Corp. of America Holdings announced its plan to buy PAML, CellNetix bought back the 22% minority share from ...